Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected3M Return
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | BIAF | PFE | MRNA |
|---|---|---|---|
| Return | |||
| Last Price | 15.27 | — | — |
| Daily Change | + 19.48% | — | — |
| Period ReturnPast 3 Months | − 39.40% | + 11.35% | + 216.00% |
| Valuation | |||
| Market Cap | $3.24 M | $162 B | $57.5 B |
| P/E Ratio | — | — | — |
| Dividend Yield | — | — | — |
| Net MarginTrailing 12M | 257.3% | — | 141.4% |
| Risk | |||
| Beta | -1.36 | — | 1.22 |
| 52-Week Range | 4.56 — $202.50 | — | 22.28 — $176.66 |
| Company | |||
| Sector | — | Health Care | Health Care |
| Industry | Biotechnology | Pharmaceuticals | Biotechnology |
Company
- BIAFBiotechnology
- PFEHealth Care · Pharmaceuticals
- MRNAHealth Care · Biotechnology
Metrics could not be loaded for PFE: P/E, dividend, beta and the 52-week range stay empty in that column.
FinnhubUpdated 23:00
To Understand This